BlogZone Get the app
Health

DNA treatment cuts bad cholesterol by nearly 50% without statins

Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice after a single injection.

BlogZone shows headlines and summaries from public news feeds. The full story is published by ScienceDaily Health.

Read the full story at ScienceDaily Health →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Health